PW Medtech GroupFRA:PWE -1.82%83 Gross Margin % is 47.58% as of Dec. 2025, which is 21% below its 10-year median of 60.46. GuruFocus rates FRA:PWE with a GF Score™ of 83/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review. Among 805 Medical Devices & Instruments companies, PW Medtech Group ranks worse than 53.54% on this metric.
PW Medtech Group Ltd gross margin has been in long-term decline. The average rate of decline per year is -3.7%.
The historical rank and industry rank for PW Medtech Group's Gross Margin % or its related term are showing as below:
FRA:PWE'
s Gross Margin % Range Over the Past 10 Years
Min: 49.47 Med: 60.46 Max: 65.81
Current: 49.47
During the past 13 years, the highestGross Margin % of PW Medtech Group was 65.81%. The lowest was 49.47%. And the median was 60.46%.
FRA:PWE's Gross Margin % is ranked worse than 53.54% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs FRA:PWE: 49.47
PW Medtech Group had a gross margin of 47.58% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for PW Medtech Group was -3.70% per year.
PW Medtech Group (FRA:PWE) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PW Medtech Group had a gross margin of 47.58% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PW Medtech Group Gross Margin % Related Terms
PW Medtech Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PWE vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PW Medtech Group (FRA:PWE) has a Gross Margin % of 47.58% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on PW Medtech Group and its competitors. This is 21% below median its historical median of 60.46. Over the past decade, PW Medtech Group's Gross Margin % has ranged from 49.47 to 65.81. According to the industry distribution chart, PW Medtech Group ranks #431 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 53.5%.
Is PW Medtech Group's Gross Margin % too high?
PW Medtech Group's current Gross Margin % of 47.58% is 21% below median its 10-year median of 60.46. Over the past 10 years, this metric has ranged from a low of 49.47 to a high of 65.81. The Medical Devices & Instruments industry median Gross Margin % is 51.94. PW Medtech Group's value of 47.58% is 8.4% below this industry median. Based on the distribution chart, PW Medtech Group ranks #431 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, PW Medtech Group has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #431 out of 805 companies for Gross Margin %. This places PW Medtech Group in the lower half of its industry. The industry median Gross Margin % is 51.94. PW Medtech Group's value of 47.58% is 8.4% below this benchmark. Historically, PW Medtech Group's own Gross Margin % has ranged from 49.47 to 65.81 over the past decade. While the company's 10-year median is 60.46 vs. the industry median of 51.94, PW Medtech Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PW Medtech Group's current Gross Margin % of 47.58% is 8.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PW Medtech Group and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PW Medtech Group's current Gross Margin % is 47.58%, which is 21% below median its own 10-year median of 60.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current Gross Margin % of 47.58%. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 16.9% below its estimated fair value. The current Gross Margin % is 47.58%, which is 21% below median its 10-year median of 60.46 and 8.4% below the Medical Devices & Instruments industry median of 51.94. PW Medtech Group's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current Gross Margin % is 47.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.11 is trading 16.9% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:PWE:
Gross Margin %: 47.58% (21% below median its 10-year median of 60.46)
GF Value™: €0.13 vs. price of €0.11 (16.9% below fair value)
Industry Position: 8.4% below the Medical Devices & Instruments median (#431 of 805)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
83GF Score
Get the complete analysis for FRA:PWE
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
